Clinical trials
Enrolling by invitation Amyloid Neuropathies, Familial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Anzhen Hospital | 1 |
| Cedars-Sinai Medical Center | 1 |
| Intellia Therapeutics | 1 |
| Kotyora Family Medicine Health Management and Education Association | 1 |
| University of Tennessee Graduate School of Medicine | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloid Neuropathies, Familial | 6 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
| Amyloidosis | 1 |
| Carpal Tunnel Syndrome | 1 |
| Spinal Stenosis | 1 |
Trials
Showing 51 to 6 of 6. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.